Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That’s because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley “insiders” right to you…

• He was one of five people involved in early meetings for the $160 billion “cloud” computing phenomenon.
• He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
• As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.

This all means the entire world is constantly seeking Michael’s insight.

In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse – years before the word “bailout” became a household word.

Silicon Valley defense publications vie for his analysis. He’s worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.

And even with decades of experience, Michael believes there has never been a moment in time quite like this.

Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.

To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.

His other publications include: Strategic Tech Investor, The Nova-X Report, and Nexus-9 Network.

To find out more about Michael and his publications, click on the links below.
Michael A. Robinson
Nova-X Report
Nexus-9 Network
Bio-Technology Profit Alliance

Nova-X Report puts you directly in touch with high-tech research, analysis, stock picks, and strategies that can double, triple, even quadruple your retirement savings faster than any other sector on earth. It’s led by 35-year Silicon Valley insider Michael A. Robinson, who has uncovered nearly every major tech breakthrough since the personal computer, making a fortune for his readers in the process. The key to winning in tech investing is to ignore the hype, while pouncing only on companies that offer real growth. Michael shows you how to do this every month. Today, he’s following some of the most lucrative tech trends in history – including mobile technology, “Big Data,” the Cloud, biotechnology… and more. Each issue shows you exactly how to capitalize on these opportunities for the biggest gains… while safely protecting your retirement. Learn More

Right now, mind-blowing new technologies are hitting the market faster than ever before. These go way beyond simply new, or innovative, or even astounding. These are truly radical technologies. But, with a sector so broad as tech, you can’t just stop at technologies as a whole when searching for profit opportunities. When you whittle down the world into the nine distinct sub-sectors constituting the “best of the best,” you have the opportunity to truly create a fortune that could last a generation. And that’s what members of the Nexus-9 Network receive – everything from the artificially intelligent robotics world to next-generation biotechnology solutions. Learn More

Now that governments and businesses around the world are pouring tens of billions of dollars into biotech research and development, the entire sector is taking the world’s center stage. The typical long and tedious years it would normally take medical advancements to come to market is compressing, which is accelerating and creating more profit opportunities than ever before – so long as you can see ahead of the trend. That’s why the Bio-Technology Profit Alliance was created. With over 50 recommendations in the course of the next year alone, you’ll be on the frontlines to watch each new innovation unfold – things like “skinny pills” that could make obesity a thing of the past, smart contact lenses that treat glaucoma, diabetic retinopathy, vein occlusion, and even a surgically implanted memory chip that reverses memory loss from stroke and Alzheimer’s. You can guess by now that, when you are on the right side, you’ll have the opportunity to make over 10 times your money as each one develops. Just click here to learn more. Learn More

By submitting your email address you will receive a free subscription to Strategic Tech Investor and occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.​​